First, the good news.
Excellent progress with our work on boron therapeutics, as well as gearing up for new insights into the lamina of trypanosomes, suramin MoA and several others.
Also, Martin Zoltner will be moving to his own lab at BIOCEV in Praha. Congrats on this and we hope to continue to work closely with him going forward.
Also some really excellent collaborations moved forward this year, with Colin Sutherland, Pascal Maser and many others.
Now, the bad news.
This one is obvious – and we remain in a limbo concerning the Brexit debacle, and hoping for some sanity, which looks increasing like a fantasy. We live in hope….